The following pages link to Tianxi Cai (Q75169):
Displaying 50 items.
- L1-Regularized Least Squares for Support Recovery of High Dimensional Single Index Models with Gaussian Designs (Q2810910) (← links)
- A predictive enrichment procedure to identify potential responders to a new therapy for randomized, comparative controlled clinical studies (Q2827203) (← links)
- Reply to Sabanés Bové and Held's “Comment on Cai and Betensky (2003), On the Poisson Approximation for Hazard Regression” (Q2861977) (← links)
- Model checking techniques for assessing functional form specifications in censored linear regression models (Q2883897) (← links)
- Evaluating prognostic accuracy of biomarkers in nested case-control studies (Q2893221) (← links)
- Graphical Procedures for Evaluating Overall and Subject-Specific Incremental Values from New Predictors with Censored Event Time Data (Q2893397) (← links)
- Evaluating Prognostic Accuracy of Biomarkers under Competing Risk (Q2912330) (← links)
- Evaluating marker-guided treatment selection strategies (Q2927594) (← links)
- Robust Prediction of t-Year Survival with Data from Multiple Studies (Q3013973) (← links)
- The Highest Confidence Density Region and Its Usage for Joint Inferences about Constrained Parameters (Q3013990) (← links)
- Hazard Regression for Interval-Censored Data with Penalized Spline (Q3079154) (← links)
- Nonparametric Evaluation of Biomarker Accuracy Under Nested Case-Control Studies (Q3095176) (← links)
- (Q3096118) (← links)
- Kernel Machine Approach to Testing the Significance of Multiple Genetic Markers for Risk Prediction (Q3100801) (← links)
- Comparing costs associated with risk stratification rules for t-year survival (Q3165530) (← links)
- Identifying Subjects Who Benefit from Additional Information for Better Prediction of the Outcome Variables (Q3183238) (← links)
- A Perturbation Method for Inference on Regularized Regression Estimates (Q3225803) (← links)
- Analysis of randomized comparative clinical trial data for personalized treatment selections (Q3303673) (← links)
- On the covariate-adjusted estimation for an overall treatment difference with data from a randomized comparative clinical trial (Q3303813) (← links)
- Exact and efficient inference procedure for meta-analysis and its application to the analysis of independent 2 x 2 tables with all available data but without artificial continuity correction (Q3304961) (← links)
- The sensitivity and specificity of markers for event times (Q3434133) (← links)
- Sparse kernel machine regression for ordinal outcomes (Q3465724) (← links)
- Robust combination of multiple diagnostic tests for classifying censored event times (Q3526150) (← links)
- (Q3534824) (← links)
- Semiparametric Models of Time-Dependent Predictive Values of Prognostic Biomarkers (Q3561800) (← links)
- Calibrating parametric subject-specific risk estimation (Q3585402) (← links)
- Semiparametric Box–Cox power transformation models for censored survival observations (Q3597963) (← links)
- Predicting future responses based on possibly mis-specified working models (Q3631481) (← links)
- Time-Dependent Predictive Values of Prognostic Biomarkers With Failure Time Outcome (Q3632645) (← links)
- Semiparametric Mixed-Effects Models for Clustered Failure Time Data (Q4468403) (← links)
- Semiparametric Receiver Operating Characteristic Analysis to Evaluate Biomarkers for Disease (Q4468509) (← links)
- Augmented estimation for t‐year survival with censored regression models (Q4556698) (← links)
- A general statistical framework for subgroup identification and comparative treatment scoring (Q4556703) (← links)
- Analysis of multiple diverse phenotypes via semiparametric canonical correlation analysis (Q4556710) (← links)
- Two-Sample Tests for High-Dimensional Linear Regression with an Application to Detecting Interactions (Q4602115) (← links)
- Multiple Testing of Submatrices of a Precision Matrix With Applications to Identification of Between Pathway Interactions (Q4690961) (← links)
- Landmark Prediction of Long-Term Survival Incorporating Short-Term Event Time Information (Q4904726) (← links)
- Evaluating the Predictive Value of Biomarkers with Stratified Case‐Cohort Design (Q4911947) (← links)
- Semi-Supervised Approaches to Efficient Evaluation of Model Prediction Performance (Q4962081) (← links)
- Nonparametric Maximum Likelihood Estimators of Time-Dependent Accuracy Measures for Survival Outcome Under Two-Stage Sampling Designs (Q4962452) (← links)
- Landmark Estimation of Survival and Treatment Effect in a Randomized Clinical Trial (Q4975358) (← links)
- Evaluating Incremental Values from New Predictors with Net Reclassification Improvement in Survival Analysis (Q4984857) (← links)
- Estimating average treatment effects with a double‐index propensity score (Q4998678) (← links)
- (Q4999104) (← links)
- Optimal Statistical Inference for Individualized Treatment Effects in High-Dimensional Models (Q5087409) (← links)
- Using a surrogate marker for early testing of a treatment effect (Q5121040) (← links)
- The Performance of Risk Prediction Models (Q5123081) (← links)
- Efficient and Robust Estimation of τ-year Risk Prediction Models Leveraging Time Varying Intermediate Outcomes (Q5155199) (← links)
- Semi‐supervised validation of multiple surrogate outcomes with application to electronic medical records phenotyping (Q5214446) (← links)
- Automated feature selection of predictors in electronic medical records data (Q5214471) (← links)
